Details for: CL0000818

Cell ID: CL0000818

Cell Name: transitional stage B cell

Description: This cell type is compatible with the HIPC Lyoplate markers for 'transitional B cell'.

Synonyms: T1 B cell, T2 B cell, T3 B cell, transitional stage B lymphocyte, transitional stage B-cell, transitional stage B-lymphocyte, transitional B cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for transitional stage B cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for transitional stage B cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for transitional stage B cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for transitional stage B cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  transitional stage B cell (CL0000818)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [transitional stage B cell](/details-cell/CL0000818), also known as T1, T2, or T3 B cell, represents an immature B lymphocyte population bridging the developmental gap between bone marrow precursors and mature peripheral B cells. The gene significance profile, based on expression specificity (**Overall** context), strongly suggests that this cell type is defined not by unique immune effector molecules but by an exceptionally high level of foundational cellular activities. The top markers are overwhelmingly dominated by genes involved in mitochondrial respiration, protein translation, and transcriptional regulation. This indicates that the transitional stage is a period of intense metabolic activity and cellular reprogramming, preparing the cell for its subsequent roles in the adaptive immune system. ## Key Characteristics and Function Analysis of top marker genes, ranked by expression specificity (`csi_z`), reveals several core functional clusters that define the [transitional stage B cell](/details-cell/CL0000818). * **High Metabolic Activity:** A strikingly large number of the most specific markers are components of the mitochondrial electron transport chain. These include multiple subunits of NADH dehydrogenase ([ND1](/details-gene/4535), [ND2](/details-gene/4536), [ND3](/details-gene/4537), [ND4](/details-gene/4538)), cytochrome c oxidase ([COX1](/details-gene/4512), [COX2](/details-gene/4513), [COX4I1](/details-gene/1327), [COX7C](/details-gene/1350)), ATP synthase ([ATP6](/details-gene/4508)), and cytochrome b ([CYTB](/details-gene/4519)). This metabolic signature points to a high demand for ATP production through aerobic respiration, likely fueling the significant biosynthetic and developmental processes required during this transitional phase. * **Active Protein Synthesis and Processing:** The profile is enriched for genes essential for translation, such as translation elongation factors [EEF1B2](/details-gene/1933) and [EEF1D](/details-gene/1936), and the translationally controlled tumor protein [TPT1](/details-gene/7178). This is consistent with a state of active growth and the production of proteins necessary for maturation and the establishment of the B cell receptor complex. * **Transcriptional and Post-Transcriptional Regulation:** A significant cluster of top markers includes genes involved in regulating gene expression and RNA processing. [BTG1](/details-gene/694), a known anti-proliferative gene involved in transcriptional coregulation ([Link](https://doi.org/10.1002/j.1460-2075.1992.tb05213.x)), and the general transcription factor [BTF3](/details-gene/689) highlight active transcriptional control. Furthermore, the high specificity of RNA helicases and splicing factors like [DDX5](/details-gene/1655), [PNISR](/details-gene/25957), and [RBM39](/details-gene/9584) suggests that extensive mRNA processing and alternative splicing are critical activities, likely for generating the diverse proteome required for B cell maturation. * **Antigen Presentation and Cell Identity:** The high specificity of [B2M](/details-gene/567) and the non-classical MHC molecule [HLA E](/details-gene/3133) underscores the importance of MHC class I-related pathways. While B cells are known for MHC class II antigen presentation, a robust MHC class I system is vital for self-recognition and interaction with NK and T cells. * **Cellular Lineage and Excluded Functions:** The anti-marker profile helps to define what this cell is not. The low specificity score for [TYROBP](/details-gene/7305), a key signaling adapter in myeloid and NK cells, confirms the cell's distinct lymphoid lineage. Interestingly, core B-cell receptor components like [CD79A](/details-gene/973) also show low expression *specificity*. This does not imply absence, but rather suggests that its expression level is not uniquely high in transitional B cells when compared to the broader landscape of all cell types, which likely includes other B cell subsets where it is also constitutively expressed. ## Clinical Significance and Contextual Roles **Overall**, the gene expression profile of the [transitional stage B cell](/details-cell/CL0000818) highlights its nature as a highly active, developing cell. This has potential implications for understanding lymphoproliferative disorders. For instance, the high significance of [BTG1](/details-gene/694) is noteworthy, as this gene locus is involved in a chromosomal translocation found in B-cell chronic lymphocytic leukemia ([Link](https://doi.org/10.1002/j.1460-2075.1992.tb05213.x)), suggesting that deregulation of transcriptional control at this stage could contribute to malignancy. The profound metabolic signature, driven by mitochondrial gene expression, indicates a potential vulnerability. Cancers of lymphoid origin often exhibit high metabolic rates, and the machinery that is highly active in these transitional cells may be co-opted or deregulated during transformation. The presence of RNA processing factors like [RBM39](/details-gene/9584) may also be clinically relevant. Splicing machinery is increasingly recognized as a therapeutic target in cancer, and the dependence of these cells on such factors could inform future therapeutic strategies for B-cell malignancies that may arise from or mimic this developmental stage. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The dominant gene signature of mitochondrial respiration and protein synthesis suggests that the primary function of the [transitional stage B cell](/details-cell/CL0000818) is not immediate effector activity but rather to achieve a state of high metabolic readiness. This "metabolic priming" is likely essential to fuel the rapid clonal expansion and differentiation that must occur upon successful antigen encounter and T-cell help. * **Surprising Findings:** The most specific markers for this cell type are not canonical B-cell surface receptors but are instead components of universal, high-energy cellular processes. This implies that what distinguishes the transitional B cell from other cells in a systems-level analysis is the sheer *rate* and *scale* of its metabolic and biosynthetic activity, rather than the expression of a few unique proteins. * **Testable Questions:** How does the metabolic flux through the electron transport chain in transitional B cells compare to that in mature naive and memory B cells at baseline and upon stimulation? Furthermore, would pharmacologic inhibition of key metabolic checkpoints (e.g., ATP synthase) disproportionately impair the survival and differentiation of transitional B cells? 2. **Hypothesis:** The concurrent high expression specificity of an anti-proliferative transcription factor, [BTG1](/details-gene/694), alongside machinery for massive biosynthesis, suggests a tightly-regulated "poised" state. Transitional B cells may be held in the G1 phase of the cell cycle by factors like [BTG1](/details-gene/694) ([Link](https://doi.org/10.1002/j.1460-2075.1992.tb05213.x)), allowing them to accumulate the metabolic and transcriptional resources required for rapid proliferation while awaiting a definitive activation signal. This would serve as a critical checkpoint to prevent inappropriate or premature expansion of the immature B cell pool. * **Surprising Findings:** It is counterintuitive for an anti-proliferative gene like [BTG1](/details-gene/694) to be a top defining marker of a cell type that is a prelude to massive expansion. This apparent paradox points towards a sophisticated regulatory network where cells are actively restrained from proliferation while they undergo critical developmental reprogramming, governed by the numerous highly expressed splicing and transcription factors. * **Testable Questions:** Does knockdown of [BTG1](/details-gene/694) in transitional B cells lead to increased cell cycling and proliferation in the absence of canonical BCR stimulation? Conversely, does overexpression of [BTG1](/details-gene/694) arrest their maturation into follicular or marginal zone B cells following stimulation?